Medical groups question price of new hep C drugWASHINGTON (AP) â€" An innovative hepatitis C drug that was only recently hailed as a breakthrough treatment is facing skepticism from some health care providers, as they consider whether it is worth the $1,000-a-pill price set by manufacturer Gilead Sciences Inc.
Source: Medical groups question price of new hep C drug (http://news.yahoo.com/medical-groups-price-hep-c-drug-151343228--finance.html)